Does CYCLOPHOSPHAMIDE Cause Product use in unapproved indication? 5,750 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5,750 reports of Product use in unapproved indication have been filed in association with CYCLOPHOSPHAMIDE (Cyclophosphamide). This represents 4.5% of all adverse event reports for CYCLOPHOSPHAMIDE.
5,750
Reports of Product use in unapproved indication with CYCLOPHOSPHAMIDE
4.5%
of all CYCLOPHOSPHAMIDE reports
1,245
Deaths
1,392
Hospitalizations
How Dangerous Is Product use in unapproved indication From CYCLOPHOSPHAMIDE?
Of the 5,750 reports, 1,245 (21.7%) resulted in death, 1,392 (24.2%) required hospitalization, and 447 (7.8%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CYCLOPHOSPHAMIDE. However, 5,750 reports have been filed with the FAERS database.
What Other Side Effects Does CYCLOPHOSPHAMIDE Cause?
Off label use (12,578)
Febrile neutropenia (11,318)
Drug ineffective (8,142)
Neutropenia (7,352)
Disease progression (7,100)
Pyrexia (6,126)
Thrombocytopenia (4,669)
Pneumonia (4,595)
Nausea (4,561)
Anaemia (4,486)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
CYCLOSPORINE (5,019)
Which CYCLOPHOSPHAMIDE Alternatives Have Lower Product use in unapproved indication Risk?
CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE FOR , USP
CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE
CYCLOPHOSPHAMIDE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE
CYCLOPHOSPHAMIDE vs CYCLOSERINE
CYCLOPHOSPHAMIDE vs CYCLOSPORINE